A more detailed understanding of cholinergic interneuron vulnerability to torsinA LOF and the nature of the contribution of their aberrant function to DYT1 dystonia could provide new concepts for therapeutic development before and after a critical period. This evidence concerns the gene TOR1A and Dystonia.